Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
CanSino Biologics Inc. (688185)
- 61.51
- -1.79-2.83%
Market Closed Apr 30 15:00 CST
15.20BMarket Cap-15377.50P/E (TTM)
63.48High61.45Low2.31MlotVolume63.06Open63.30Prev Close143.39MTurnover2.02%Turnover Ratio544.34P/E (Static)247.04MShares92.7052wk High3.08P/B7.04BFloat Cap55.2052wk Low75.96Limit Up114.37MShs Float797.20Historical High50.64Limit Down3.21%Range %37.12Historical Low--Dividend TTM62.17Avg Price1.37MlotAsk--Div Yield TTM1Lot Size894.16KlotBid
CanSino Biologics Inc. (688185) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.44%178.25M | 37.95%1B | 36.12%698.53M | 41.41%439.92M | 45.56%194.68M | 49.16%726.32M | 64.83%513.17M | 116.47%311.1M | 139.18%133.75M | 14.65%486.94M |
| Refunds of taxes and levies | ---- | -57.65%19.9M | -63.42%17.18M | -47.97%17.22M | -99.60%110.96K | -66.75%46.98M | -64.93%46.98M | 31.07%33.1M | 63.35%27.81M | 5.53%141.28M |
| Cash received relating to other operating activities | -48.93%20.66M | -14.77%125.05M | 94.80%97.01M | 128.71%87.29M | 187.26%40.46M | -33.09%146.72M | -70.80%49.8M | -64.72%38.17M | -79.09%14.08M | -31.63%219.28M |
| Cash inflows from operating activities | -15.45%198.91M | 24.66%1.15B | 33.25%812.73M | 42.39%544.44M | 33.93%235.25M | 8.56%920.01M | -0.95%609.95M | 37.96%382.37M | 25.20%175.65M | -3.62%847.5M |
| Goods services cash paid | -9.26%45.38M | 32.06%229.94M | 130.36%140.85M | 29.95%97.96M | 174.40%50.02M | -68.26%174.12M | -82.88%61.14M | -73.70%75.38M | -82.04%18.23M | -59.76%548.57M |
| Staff behalf paid | 8.93%95.48M | -11.59%423.64M | -17.38%330.03M | -23.03%228.31M | -29.35%87.65M | -31.44%479.2M | -25.16%399.47M | -24.55%296.62M | -20.88%124.06M | 14.90%698.93M |
| All taxes paid | 11.40%8.63M | 62.03%44.83M | 96.65%30.68M | 215.13%19.42M | 605.84%7.74M | -20.89%27.67M | -51.38%15.6M | -79.52%6.16M | -95.42%1.1M | -38.15%34.97M |
| Cash paid relating to other operating activities | 12.35%116.44M | -12.00%357.54M | -34.07%277.68M | -14.18%187.48M | -26.21%103.65M | -14.14%406.31M | -4.69%421.15M | -28.32%218.45M | -30.97%140.46M | -32.66%473.26M |
| Cash outflows from operating activities | 6.78%265.93M | -2.88%1.06B | -13.16%779.23M | -10.64%533.16M | -12.26%249.05M | -38.07%1.09B | -34.25%897.37M | -41.19%596.61M | -41.56%283.84M | -35.71%1.76B |
| Net cash flows from operating activities | -385.60%-67.02M | 154.39%90.98M | 111.65%33.49M | 105.26%11.28M | 87.24%-13.8M | 81.58%-167.29M | 61.63%-287.41M | 70.95%-214.24M | 68.68%-108.2M | 50.95%-908.23M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -44.70%1.21B | -37.78%7.63B | -30.26%6.2B | -8.09%4.77B | 9.75%2.19B | 55.13%12.27B | 36.31%8.89B | 31.90%5.19B | -26.10%2B | -32.23%7.91B |
| Cash received from returns on investments | 25.05%8.76M | -49.92%44.97M | -57.80%28.55M | -62.36%19.64M | -83.55%7M | 45.79%89.8M | 32.18%67.66M | 80.51%52.17M | 141.14%42.57M | -42.52%61.59M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 1,392.63%559.73K | 673.17%289.94K | ---- | ---- | -87.99%37.5K | -26.47%37.5K | ---- | ---- | --312.37K |
| Cash received relating to other investing activities | -24.58%103.57M | -49.07%544M | -67.52%207.66M | -71.25%172M | -77.05%137.32M | 169.17%1.07B | 818.91%639.4M | 759.86%598.31M | 759.86%598.31M | -9.41%396.83M |
| Cash inflows from investing activities | -43.31%1.32B | -38.76%8.22B | -32.94%6.43B | -15.04%4.96B | -11.45%2.33B | 60.47%13.42B | 44.48%9.59B | 44.81%5.84B | -5.42%2.64B | -31.50%8.37B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -53.87%31.08M | -46.70%243.9M | -45.21%178.62M | -48.91%134.39M | -49.88%67.36M | -25.04%457.64M | -27.11%326.03M | -17.44%263.05M | -37.55%134.42M | -43.21%610.47M |
| Cash paid to acquire investments | -54.00%1.18B | -38.93%7.44B | -32.87%6.4B | -9.84%4.92B | 19.67%2.57B | 78.08%12.18B | 80.96%9.53B | 87.61%5.46B | 0.44%2.15B | -44.39%6.84B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | 288.02%1.31M | ---- | ---- | ---- | --336.99K |
| Cash paid relating to other investing activities | 26.32%166.73M | -75.97%189.27M | -51.96%189.27M | 50.15%189.27M | 70.56%131.99M | -42.41%787.52M | -65.39%393.98M | -85.67%126.05M | -87.19%77.39M | 1,865.27%1.37B |
| Cash outflows from investing activities | -50.17%1.38B | -41.37%7.87B | -33.99%6.77B | -10.30%5.25B | 17.38%2.77B | 52.26%13.42B | 49.58%10.25B | 42.36%5.85B | -20.21%2.36B | -34.41%8.82B |
| Net cash flows from investing activities | 86.79%-57.79M | 14,210.90%352.36M | 49.48%-331.39M | -2,850.48%-285.52M | -259.03%-437.36M | 100.55%2.46M | -209.75%-655.97M | 87.27%-9.68M | 259.88%275.01M | 63.37%-449.65M |
| Financing cash flow | ||||||||||
| Cash from borrowing | ---- | -23.73%795.66M | 7.96%765.66M | 18.28%634.75M | -8.64%288.22M | -36.18%1.04B | -46.30%709.2M | -46.39%536.63M | -23.01%315.48M | -37.95%1.63B |
| Cash received relating to other financing activities | --66.26K | 4.38%7.34M | --7.34M | --1.44M | ---- | -89.60%7.03M | ---- | ---- | ---- | --67.59M |
| Cash inflows from financing activities | -99.98%66.26K | -23.54%803M | 9.00%773M | 18.55%636.2M | -8.64%288.22M | -38.30%1.05B | -48.37%709.2M | -49.08%536.63M | -23.04%315.48M | -35.39%1.7B |
| Borrowing repayment | -60.58%126.07M | 15.87%1.51B | 52.08%1.35B | 23.04%752.36M | 114.08%319.84M | -18.30%1.3B | -37.22%884.88M | -50.25%611.47M | -61.90%149.41M | 16.80%1.6B |
| Dividend interest payment | -45.15%7.14M | -30.22%44.51M | -25.65%36.63M | -24.43%25.42M | -22.41%13.03M | -13.51%63.78M | -14.91%49.27M | -15.22%33.64M | -27.18%16.79M | -69.44%73.75M |
| Cash payments relating to other financing activities | -58.83%704.95K | -12.08%15.33M | 56.30%12.44M | 10.10%5.32M | -10.29%1.71M | -57.29%17.43M | -78.80%7.96M | -69.32%4.83M | -63.16%1.91M | -76.42%40.82M |
| Cash outflows from financing activities | -59.97%133.92M | 13.40%1.57B | 48.05%1.39B | 20.49%783.1M | 99.03%334.58M | -19.03%1.38B | -37.39%942.1M | -49.40%649.94M | -60.01%168.1M | -3.95%1.71B |
| Net cash flows from financing activities | -188.70%-133.86M | -129.48%-766.9M | -166.98%-621.81M | -29.65%-146.9M | -131.46%-46.37M | -4,307.54%-334.18M | -77.36%-232.9M | 50.87%-113.31M | 1,506.94%147.37M | -100.89%-7.58M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -159.05%-6.76M | -248.96%-12.98M | -595.50%-6.14M | -153.90%-6.68M | -117.85%-2.61M | -57.04%8.72M | -101.70%-882.16K | -66.36%12.39M | 175.02%14.62M | -87.38%20.29M |
| Net increase in cash and cash equivalents | 46.93%-265.43M | 31.36%-336.54M | 21.35%-925.85M | -31.70%-427.82M | -252.11%-500.14M | 63.55%-490.29M | -13.16%-1.18B | 67.75%-324.84M | 160.07%328.81M | 34.83%-1.35B |
| Add:Begin period cash and cash equivalents | -21.63%1.22B | -23.96%1.56B | -23.96%1.56B | -23.96%1.56B | -23.96%1.56B | -39.67%2.05B | -39.67%2.05B | -39.67%2.05B | -39.67%2.05B | -37.84%3.39B |
| End period cash equivalent | -9.65%953.84M | -21.63%1.22B | -27.50%629.96M | -34.47%1.13B | -55.55%1.06B | -23.96%1.56B | -63.04%868.93M | -27.80%1.72B | -16.49%2.37B | -39.67%2.05B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm